NEW MODELS OF CARE & VALUE IN GENERAL PRACTICE
Dr Michael Wright, GP, Adjunct Associate Professor
International Centre for Future Health Systems (ICFHS)
University of New South Wales (UNSW) &
President, The Royal Australian College of General Practitioners (RACGP)
RESEARCHER PROFILE
Filmed in Sydney, Australia | September 2025
Dr Michael Wright is a GP, health economist and health services researcher. Dr Wright currently works as a portfolio GP, combining clinical practice with strategic appointments (most recently with RACGP, Central and Eastern Sydney Primary Health Network, Avant Mutual the Australian Institute of Health and Welfare) and academic research analysing the effects of current health policy on the quality and performance of primary care. Dr Wright previously worked in London as a clinician, a Leadership Consultant with The King’s Fund, and was a researcher at the London School of Hygiene and Tropical Medicine. Dr Wright completed his PhD at the Centre for Health Economics Research and Evaluation (CHERE) at the University of Technology Sydney (UTS) in 2019. His PhD investigated the impact of continuity of general practice care on health outcomes, and his research interests including health funding and health policy research into quality, efficiency and sustainability of health services.
Source: UNSW Sydney website
-
Professor Sandy Middleton
NURSING RESEARCH INSTITUTE, ST VINCENT’S HEALTH NETWORK SYDNEY, ST VINCENT’S HOSPITAL MELBOURNE AND AUSTRALIAN CATHOLIC UNIVERSITY
NEW SOUTH WALES, AUSTRALIA -
Novel immunotherapies in lymphoma
Dr Sean Harrop is a dual-trained haematologist having completed his clinical and laboratory haematology training at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and St Vincent’s Hospital Melbourne. He is the current clinical haematology fellow (aggressive lymphoma) at Peter MacCallum and a PhD student in the Cancer Immunology Program in the Neeson Lab.
-
Next-generation NK cell-based immunotherapies for hard-to-treat cancers
Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.
